Product image of Glucotrol Xl (Glipizide) supplied by GNH India

Glucotrol Xl

Active Ingredient:
Glipizide
Origin:
EU

Glucotrol Xl (Glipizide)

Glucotrol Xl is a prescription oral medication whose active ingredient is glipizide. It belongs to the sulfonylurea class of antidiabetic agents and is marketed in the European Union. The product is formulated for oral administration, although the specific dosage strength and tablet form are not disclosed in the available data.

Manufacturer / TM Owner

Pfizer Luxembourg S.À.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucotrol Xl is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and other non‑pharmacologic measures are insufficient. It is used as part of a comprehensive diabetes care plan to improve glycemic control.

  • Adjunct to diet and exercise for type 2 diabetes
  • May be combined with other oral antidiabetic agents
  • Helps lower fasting and post‑prandial blood glucose levels
  • Used when other monotherapy options are inadequate
  • Considered for patients who respond to sulfonylurea therapy

Side Effects

Glucotrol Xl can cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require medical attention.

Common

  • Hypoglycemia (low blood sugar)
  • Nausea or abdominal discomfort
  • Weight gain
  • Dizziness or light‑headedness
  • Headache

Serious

  • Severe allergic reactions (rash, swelling, difficulty breathing)
  • Hemolytic anemia
  • Liver function abnormalities
  • Pancreatitis
  • Persistent low blood glucose requiring assistance

Precautions & Warnings

Before starting Glucotrol Xl, patients should discuss their medical history and current health status with a healthcare professional. Certain conditions and factors increase the risk of adverse outcomes.

  • Known hypersensitivity to glipizide or sulfonylureas
  • History of severe hypoglycemia
  • Significant renal or hepatic impairment
  • Pregnancy, breastfeeding, or planning pregnancy
  • Elderly patients may be more susceptible to hypoglycemia
  • Concomitant use of other glucose‑lowering agents

Avoid Interactions

Glucotrol Xl may interact with other medications, affecting its efficacy or safety. Some combinations should be avoided, while others require careful monitoring.

Avoid

  • Other sulfonylureas or insulin secretagogues
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone)
  • Medications that can cause hypoglycemia (e.g., quinine)

Use with caution

  • Beta‑blockers (may mask hypoglycemia symptoms)
  • Thiazide diuretics (can increase blood glucose)
  • NSAIDs and aspirin (may affect renal function)
  • Anticoagulants (potential for altered blood sugar control)

Frequently Asked Questions

Glucotrol Xl contains the active ingredient glipizide, which is a sulfonylurea oral antidiabetic medication.

Glipizide stimulates insulin release from pancreatic beta cells by binding to the sulfonylurea receptor and closing ATP‑sensitive potassium channels, which helps lower blood glucose.

Glucotrol Xl is marketed in the European Union; its regulatory status in the United States may differ and should be confirmed with local health authorities.

Glucotrol Xl can be combined with other oral antidiabetic agents, but any combination should be supervised by a healthcare professional to avoid hypoglycemia.

Common side effects include hypoglycemia, nausea, weight gain, dizziness, and headache.

Medical attention is needed for signs of severe hypoglycemia, allergic reactions such as rash or swelling, persistent nausea, or any symptoms of liver or pancreatic problems.

Patients should follow a balanced diet as advised by their clinician; abrupt changes in carbohydrate intake can affect blood glucose control while on glipizide.

Renal impairment can increase the risk of hypoglycemia with glipizide, so dose adjustments or alternative therapies may be considered.

The safety of glipizide during pregnancy has not been fully established; pregnant individuals should discuss alternatives with their healthcare provider.

Blood glucose levels, signs of hypoglycemia, liver function tests, and renal function should be monitored periodically.

Alcohol can increase the risk of hypoglycemia and should be consumed cautiously, if at all, while taking glipizide.

Glipizide is classified under ATC code A10BB01, which denotes oral blood glucose‑lowering drugs, sulfonylureas.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glipizide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT